Search results for:
Ondine appoints senior pharma exec as Chief Medical Officer
Ondine Biomedical appoints senior pharma executive Dr. Simon Sinclair as Chief Medical Officer Vancouver, British Columbia, Canada - June 1, 2023 Canadian life sciences company Ondine Biomedical has appointed Dr. Simon Sinclair as Chief Medical Officer, as the Company prepares to start the US [...]
Ondine reports successful food pathogen study
Ondine Biomedical reports photodisinfection is highly effective against key food-borne pathogens Vancouver, British Columbia, Canada - April 20, 2023 Photodisinfection achieved complete elimination (>99.999% kill) against Salmonella enterica and 99.999% reduction of MRSA biofilm – exceeding food safety requirements Successful program made possible by [...]
Ondine Biomedical’s nasal photodisinfection cuts surgical site infections by 66%
Ondine Biomedical’s nasal photodisinfection cuts surgical site infections by 66% Vancouver, British Columbia, Canada - April 18, 2023 Routine pre-surgical use of nasal photodisinfection could prevent tens of thousands of surgical site infections a year in the US alone[i] Ondine Biomedical Inc. (LON: OBI) [...]
Ondine food-safe photodisinfection update
Ondine Biomedical to share meaty results on food-safe photodisinfection technology Vancouver, British Columbia, Canada - April 5, 2023 Canadian life sciences company, Ondine Biomedical, has concluded the first development phase of a new food-safe photodisinfection technology for Canada’s meat packing industry. The findings which will [...]
Ottawa hospital presents Steriwave study results
Nasal photodisinfection reduces hospital length of stay, readmissions and antibiotic use in substantial study at major Ottawa hospital Vancouver, British Columbia, Canada - March 3, 2023 48% shorter mean length of stay among those treated compared with those not treated (P<0.001) 51% fewer readmissions [...]
Ondine’s APDT reduces SARS-CoV-2 infectivity
Ondine’s nasal photodisinfection therapy (APDT) improves short-term and long-term immune response while significantly reducing SARS-CoV-2 infectivity Vancouver, British Columbia, Canada - January 31, 2023 This is the first randomized, placebo-controlled, single-blind clinical study of Steriwave™ nasal photodisinfection in 75 predominantly vaccinated COVID-19 patients to [...]
Photodisinfection for Biofilm Joint Infections
Photodisinfection found to eradicate biofilms associated with periprosthetic joint infections Vancouver, British Columbia, Canada - January 17, 2023 Periprosthetic joint infections are life-threatening and extremely hard-to-treat. The annual cost of treating periprosthetic joint infections in the US is $1.62 billion, with costs projected to [...]
Steriwave receives regulatory approval in Mexico
Steriwave receives regulatory approval in Mexico Vancouver, British Columbia, Canada - December 12, 2022 Photodisinfection kills all types of pathogens, including viruses, bacteria and fungi without using antibiotics Mexico’s Health Authority (COFEPRIS) has approved the sale and use of Ondine Biomedical’s Steriwave™ photodisinfection technology, which [...]
Ondine receives funding for meat photodisinfection
Ondine Biomedical receives Agriculture and Agri-Food Canada (AAFC) funding to improve food security and increase shelf-life through photodisinfection Vancouver, British Columbia, Canada - December 5, 2022 Funding of up to $735,000 towards development of prototype of novel photodisinfection application for use in food production. Up [...]
Ondine reports full results from Phase 2 nasal photodisinfection trial
Ondine Biomedical reports the full results from Phase 2 nasal photodisinfection trial Vancouver, British Columbia, Canada - December 5, 2022 Full results confirm that a single, 5-minute treatment of nasal photodisinfection significantly reduces Staphylococcus aureus, a major cause of surgical site infections, in pre-surgical patients. [...]
For Media Information
Simon Vane Percy
Amanda Bernard
